{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:17:16Z","timestamp":1787062636292,"version":"build-2736575974"},"reference-count":110,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy of Craiova, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In patients diagnosed with multiple myeloma (MM), the primary complaints at the time of diagnosis are often related to bone involvement, significantly impacting quality of life and increasing both morbidity and mortality. Obesity is associated with a chronic inflammatory state that results in the production of various cytokines and adipokines, which may promote bone destruction. Adiponectin, an adipokine predominantly secreted by adipocytes, is notably diminished in circulation among individuals with obesity, a phenomenon that has also been observed in MM. This reduction may contribute to the disruption of an already compromised bone architecture. The increase in adipose tissue is associated with heightened leptin production, a key adipokine, which can play a significant role in the pathophysiology of MM and its related bone complications. Obesity is associated with hyperinsulinemia and increased levels of free IGF-1. In MM, IGF-1 plays a critical role as a growth factor, produced by both myeloma cells and osteoclasts within the bone marrow microenvironment. Our gathered data indicates a significant relationship between the adipokines produced by adipose tissue and the bone matrix, particularly in the context of obesity and MM. However, it is important to note that the existing body of research on this topic is relatively sparse, with the majority of studies conducted on murine models rather than human subjects. This limitation highlights a critical need for further investigation to elucidate the precise mechanisms that contribute to bone destruction under these conditions.<\/jats:p>","DOI":"10.3390\/ijms26125618","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T03:59:17Z","timestamp":1749700757000},"page":"5618","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adipose Tissue-Derived Mediators in Multiple Myeloma: Linking Obesity to Bone Disease via Inflammatory Pathways"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8911-8084","authenticated-orcid":false,"given":"Alexandra-\u015etefania","family":"Stroe-Ionescu","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina Daniela","family":"T\u01cenase","sequence":"additional","affiliation":[{"name":"Department of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute Bucharest, 022328 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionela","family":"Rotaru","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina-Georgiana","family":"Goan\u021b\u01ce","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"P\u01cetra\u015fcu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2481-6138","authenticated-orcid":false,"given":"Mihail Virgil","family":"Boldeanu","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3146-8769","authenticated-orcid":false,"given":"Mohamed-Zakaria","family":"Assani","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"},{"name":"Department of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Silo\u0219i","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4817-1365","authenticated-orcid":false,"given":"Lidia","family":"Boldeanu","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3410-1334","authenticated-orcid":false,"given":"Daniela-Teodora","family":"Maria","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and Management of Multiple Myeloma: A Review","volume":"327","author":"Cowan","year":"2022","journal-title":"J. Am. Med. Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-024-00529-7","article-title":"Multiple myeloma","volume":"10","author":"Malard","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Abduh, M.S. (2024). An overview of multiple myeloma: A monoclonal plasma cell malignancy\u2019s diagnosis, management, and treatment modalities. Saudi J. Biol. Sci., 31.","DOI":"10.1016\/j.sjbs.2023.103920"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zhu, D.T., Park, A., Lai, A., Zhang, L., Attar, H., and Rebbeck, T.R. (2024). Multiple myeloma incidence and mortality trends in the United States, 1999\u20132020. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-65590-4"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am. J. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/bloodadvances.2019000524","article-title":"Long-term outcomes after autologous stem cell transplantation for multiple myeloma","volume":"4","author":"Nishimura","year":"2020","journal-title":"Blood Adv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1200\/JCO.18.00685","article-title":"Autologous Transplantation, Consolidation, and Maintenance Therapy in Multiple Myeloma: Results of the BMT CTN 0702 Trial","volume":"37","author":"Stadtmauer","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"ref_9","first-page":"2949","article-title":"Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease","volume":"2","author":"Wang","year":"2024","journal-title":"Cancer Pathog. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"104546","DOI":"10.1155\/2013\/104546","article-title":"Diagnosis and treatment of bone disease in multiple myeloma: Spotlight on spinal involvement","volume":"2013","author":"Tosi","year":"2013","journal-title":"Scientifica"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"a031286","DOI":"10.1101\/cshperspect.a031286","article-title":"Multiple Myeloma and Bone: The Fatal Interaction","volume":"8","author":"Marino","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41408-017-0037-4","article-title":"Pathogenesis of bone disease in multiple myeloma: From bench to bedside","volume":"8","author":"Terpos","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Gau, Y.C., Yeh, T.J., Hsu, C.M., Hsiao, S.Y., and Hsiao, H.H. (2022). Pathogenesis and Treatment of Myeloma-Related Bone Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063112"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mukkamalla, S.K.R., and Malipeddi, D. (2021). Myeloma Bone Disease: A Comprehensive Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126208"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2141.2010.08141.x","article-title":"Advances in the understanding of myeloma bone disease and tumour growth","volume":"149","author":"Yaccoby","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Falank, C., Fairfield, H., and Reagan, M.R. (2016). Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells. Front. Endocrinol., 7.","DOI":"10.3389\/fendo.2016.00067"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00223-016-0162-2","article-title":"Adipose, Bone, and Myeloma: Contributions from the Microenvironment","volume":"100","author":"McDonald","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.2174\/092986712803833146","article-title":"Adiponectin in metabolic bone disease","volume":"19","author":"Kanazawa","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-020-00122-0","article-title":"Adiponectin signalling in bone homeostasis, with age and in disease","volume":"9","author":"Lewis","year":"2021","journal-title":"Bone Res."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Marques-Mourlet, C., Di Iorio, R., Fairfield, H., and Reagan, M.R. (2023). Obesity and myeloma: Clinical and mechanistic contributions to disease progression. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1118691"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1182\/bloodadvances.2023010822","article-title":"It is worth the weight: Obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma","volume":"7","author":"Choa","year":"2023","journal-title":"Blood Adv."},{"key":"ref_24","unstructured":"World Health Organization (2025, May 07). Obesity and Overweight. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MCO.0000000000000690","article-title":"Current mechanisms in obesity and tumor progression","volume":"23","author":"Fosam","year":"2020","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body Fatness and Cancer\u2014Viewpoint of the IARC Working Group","volume":"375","author":"Scoccianti","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/bloodadvances.2023010843","article-title":"Mass spectrometry-detected MGUS is associated with obesity and other novel modifiable risk factors in a high-risk population","volume":"8","author":"Lee","year":"2024","journal-title":"Blood Adv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.05.033","article-title":"The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention","volume":"53","author":"Allegra","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nrendo.2014.169","article-title":"Obesity-driven disruption of haematopoiesis and the bone marrow niche","volume":"10","author":"Adler","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1611338","DOI":"10.3389\/pore.2023.1611338","article-title":"Obesity as a risk factor for multiple myeloma: Insight on the role of adipokines","volume":"29","author":"Tie","year":"2023","journal-title":"Pathol. Oncol. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.15252\/embj.201696206","article-title":"Adipose tissue: Between the extremes","volume":"36","author":"Vegiopoulos","year":"2017","journal-title":"EMBO J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, Diabetes, and Increased Cancer Progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kim, J.W., Kim, J.H., and Lee, Y.J. (2024). The Role of Adipokines in Tumor Progression and Its Association with Obesity. Biomedicines, 12.","DOI":"10.3390\/biomedicines12010097"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Melaccio, A., Reale, A., Saltarella, I., Desantis, V., Lamanuzzi, A., Cicco, S., Frassanito, M.A., Vacca, A., and Ria, R. (2022). Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance. J. Clin. Med., 11.","DOI":"10.3390\/jcm11216491"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Forte, Y.S., Renovato-Martins, M., and Barja-Fidalgo, C. (2023). Cellular and Molecular Mechanisms Associating Obesity to Bone Loss. Cells, 12.","DOI":"10.3390\/cells12040521"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12020-015-0554-5","article-title":"Preservation of high-fat diet-induced femoral trabecular bone loss through genetic target of TNF-\u03b1","volume":"50","author":"Zhang","year":"2015","journal-title":"Endocrine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1852517","DOI":"10.1155\/2017\/1852517","article-title":"Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma","volume":"2017","author":"Musolino","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2016.06.010","article-title":"Adipocytes contribute to the growth and progression of multiple myeloma: Unraveling obesity related differences in adipocyte signaling","volume":"380","author":"Bullwinkle","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/JME-16-0076","article-title":"Interleukin-6 gene knockout antagonizes high-fat-induced trabecular bone loss","volume":"57","author":"Wang","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jphs.2022.10.007","article-title":"IL-1\u03b2 promotes osteoclastogenesis by increasing the expression of IGF2 and chemokines in non-osteoclastic cells","volume":"151","author":"Otsuka","year":"2023","journal-title":"J. Pharmacol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/jlb.1A1215-543R","article-title":"IL-1\u03b2 differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets","volume":"100","author":"Cao","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.exger.2010.09.014","article-title":"Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice","volume":"46","author":"Halade","year":"2011","journal-title":"Exp. Gerontol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bone.2018.03.011","article-title":"Bone marrow adiposity and multiple myeloma","volume":"118","author":"Morris","year":"2019","journal-title":"Bone"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bone.2014.03.044","article-title":"Bone marrow fat accumulation accelerated by high fat diet is suppressed by exercise","volume":"64","author":"Styner","year":"2014","journal-title":"Bone"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jbmr.3408","article-title":"High-Fat Diet-Induced Obesity Promotes Expansion of Bone Marrow Adipose Tissue and Impairs Skeletal Stem Cell Functions in Mice","volume":"33","author":"Tencerova","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.ajpath.2016.07.012","article-title":"Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone","volume":"186","author":"Trotter","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.leu.2404658","article-title":"Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells","volume":"21","author":"Caers","year":"2007","journal-title":"Leukemia"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"34329","DOI":"10.18632\/oncotarget.6020","article-title":"Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/iub.1254","article-title":"The impact of bone marrow adipocytes on osteoblast and osteoclast differentiation","volume":"66","author":"Muruganandan","year":"2014","journal-title":"IUBMB Life"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1002\/jcp.26884","article-title":"Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma","volume":"233","author":"Morris","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"eaau9087","DOI":"10.1126\/scitranslmed.aau9087","article-title":"Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease","volume":"11","author":"Liu","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cyto.2018.06.012","article-title":"Adiponectin signaling and its role in bone metabolism","volume":"112","author":"Sanyal","year":"2018","journal-title":"Cytokine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.bone.2004.06.008","article-title":"Adiponectin and its receptors are expressed in bone-forming cells","volume":"35","author":"Berner","year":"2004","journal-title":"Bone"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jcb.20890","article-title":"Regulation of bone formation by adiponectin through autocrine\/paracrine and endocrine pathways","volume":"99","author":"Shinoda","year":"2006","journal-title":"J. Cell. Biochem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/ijpvm.IJPVM_193_20","article-title":"Adiponectin: Role in Physiology and Pathophysiology","volume":"11","author":"Nguyen","year":"2020","journal-title":"Int. J. Prev. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2003-031777","article-title":"Adiponectin relationship with lipid metabolism is independent of body fat mass: Evidence from both cross-sectional and intervention studies","volume":"89","author":"Baratta","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00592-013-0458-x","article-title":"Adiponectin increases glucose-induced insulin secretion through the activation of lipid oxidation","volume":"50","author":"Caporarello","year":"2013","journal-title":"Acta Diabetol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yexcr.2005.05.021","article-title":"Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway","volume":"309","author":"Luo","year":"2005","journal-title":"Exp. Cell Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2005.03.210","article-title":"Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast","volume":"331","author":"Oshima","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Yang, J., Park, O.J., Kim, J., Han, S., Yang, Y., Yun, C.H., and Han, S.H. (2019). Adiponectin Deficiency Triggers Bone Loss by Up-Regulation of Osteoclastogenesis and Down-Regulation of Osteoblastogenesis. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00815"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M110.152405","article-title":"Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1","volume":"286","author":"Tu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gariballa, S., Alkaabi, J., Yasin, J., and Al Essa, A. (2019). Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr. Disord., 19.","DOI":"10.1186\/s12902-019-0386-z"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/diabetes.52.7.1779","article-title":"Adiponectin expression from human adipose tissue: Relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression","volume":"52","author":"Kern","year":"2003","journal-title":"Diabetes"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10552-008-9233-7","article-title":"Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: A case-control study","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-0609.2009.01311.x","article-title":"Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma","volume":"83","author":"Reseland","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/0008-5472.CAN-15-2406","article-title":"Low Levels of Circulating Adiponectin Are Associated with Multiple Myeloma Risk in Overweight and Obese Individuals","volume":"76","author":"Hofmann","year":"2016","journal-title":"Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/oby.21894","article-title":"Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease","volume":"25","author":"Hofmann","year":"2017","journal-title":"Obesity"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1182\/blood-2011-01-330407","article-title":"Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease","volume":"118","author":"Fowler","year":"2011","journal-title":"Blood"},{"key":"ref_71","first-page":"1112","article-title":"Adiponectin inhibits the differentiation and maturation of osteoclasts via the mTOR pathway in multiple myeloma","volume":"45","author":"Liu","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jacc.2020.11.069","article-title":"Leptin in Leanness and Obesity: JACC State-of-the-Art Review","volume":"77","author":"Perakakis","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1073\/pnas.101564798","article-title":"Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF","volume":"98","author":"Cao","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cell.2015.08.055","article-title":"Sympathetic neuro-adipose connections mediate leptin-driven lipolysis","volume":"163","author":"Zeng","year":"2015","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.metabol.2014.10.021","article-title":"The role of leptin in regulating bone metabolism","volume":"64","author":"Upadhyay","year":"2015","journal-title":"Metab. Clin. Exp."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1210\/er.2017-00226","article-title":"Effects of Leptin on the Skeleton","volume":"39","author":"Reid","year":"2018","journal-title":"Endocr. Rev."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bone.2003.11.020","article-title":"Leptin deficiency produces contrasting phenotypes in bones of the limb and spine","volume":"34","author":"Hamrick","year":"2004","journal-title":"Bone"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/jbmr.406","article-title":"Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob\/ob mice","volume":"26","author":"Bartell","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Mhaidat, N.M., Alzoubi, K.H., Kubas, M.A., Banihani, M.N., Hamdan, N., and Al-Jaberi, T.M. (2021). High levels of leptin and non-high molecular weight-adiponectin in patients with colorectal cancer: Association with chemotherapy and common genetic polymorphisms. Biomed. Rep., 14.","DOI":"10.3892\/br.2020.1389"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Estevez, L., Gonz\u00e1lez-Mart\u00ednez, S., and Moreno-Bueno, G. (2021). The Leptin Axis and Its Association With the Adaptive Immune System in Breast Cancer. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.784823"},{"key":"ref_82","first-page":"8341","article-title":"Leptin promotes proliferation and inhibits apoptosis of prostate cancer cells by regulating ERK1\/2 signaling pathway","volume":"24","author":"Xu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"568","DOI":"10.21037\/atm-20-7482","article-title":"Autocrined leptin promotes proliferation of non-small cell lung cancer (NSCLC) via PI3K\/AKT and p53 pathways","volume":"9","author":"Wang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_84","first-page":"3033","article-title":"The role of adipocytokines and their receptors in bladder cancer: Expression of adiponectin or leptin is an independent prognosticator","volume":"12","author":"Kashiwagi","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_85","first-page":"241","article-title":"Leptin and resistin levels in serum of patients with hematologic malignancies: Correlation with clinical characteristics","volume":"28","author":"Pamuk","year":"2006","journal-title":"Exp. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Liu, R., Gao, D., Lv, Y., Zhai, M., and He, A. (2022). Importance of circulating adipocytokines in multiple myeloma: A systematic review and meta-analysis based on case-control studies. BMC Endocr. Disord., 22.","DOI":"10.1186\/s12902-022-00939-2"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"86075","DOI":"10.18632\/oncotarget.13342","article-title":"Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1038\/leu.2017.146","article-title":"Leptin receptor antagonism of iNKT cell function: A novel strategy to combat multiple myeloma","volume":"31","author":"Favreau","year":"2017","journal-title":"Leukemia"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1758835919846806","DOI":"10.1177\/1758835919846806","article-title":"Induction of osteoclast-like cell formation by leptin-induced soluble intercellular adhesion molecule secreted from cancer cells","volume":"11","author":"Tsai","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_90","first-page":"56","article-title":"The role of IGF-1 in obesity, cardiovascular disease, and cancer","volume":"33","author":"AsghariHanjani","year":"2019","journal-title":"Med. J. Islam. Repub. Iran"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1507\/endocrj.EJ23-0264","article-title":"A new insight into GH regulation and its disturbance from nutrition and autoimmune perspectives","volume":"70","author":"Yamamoto","year":"2023","journal-title":"Endocr. J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1073\/pnas.96.13.7324","article-title":"Normal growth and development in the absence of hepatic insulin-like growth factor I","volume":"96","author":"Yakar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: An update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ecl.2012.04.014","article-title":"The insulin-like growth factor system in cancer","volume":"41","author":"Weroha","year":"2012","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2002-05-1406","article-title":"Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor","volume":"100","author":"Standal","year":"2002","journal-title":"Blood"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1182\/blood-2008-07-170464","article-title":"The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor","volume":"113","author":"Sprynski","year":"2009","journal-title":"Blood"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1182\/blood.V93.1.235","article-title":"Insulin-like growth factor-1 acts as a chemoattractant factor for 5T2 multiple myeloma cells","volume":"93","author":"Vanderkerken","year":"1999","journal-title":"Blood"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/blood.V88.6.2250.bloodjournal8862250","article-title":"Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines","volume":"88","author":"Wiklund","year":"1996","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/sj.bjc.6601613","article-title":"Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: Study in the 5T33MM model","volume":"90","author":"Menu","year":"2004","journal-title":"Br. J. Cancer"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2141.1999.01243.x","article-title":"Potential role of insulin-like growth factor binding protein-4 in the uncoupling of bone turnover in multiple myeloma","volume":"104","author":"Feliers","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/ijc.22845","article-title":"Targeting the IGF-1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: Beneficial effects on tumor growth, angiogenesis, bone disease and survival","volume":"121","author":"Menu","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1359\/jbmr.060610","article-title":"Role of IGF-I signaling in regulating osteoclastogenesis","volume":"21","author":"Wang","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1172\/JCI59987","article-title":"Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease","volume":"125","author":"Ersek","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-014-0105-1","article-title":"Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma","volume":"8","author":"Bolomsky","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fj.201600826R","article-title":"RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice","volume":"31","author":"Kanzaki","year":"2017","journal-title":"FASEB J."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Yen, C.H., Hsu, C.M., Hsiao, S.Y., and Hsiao, H.H. (2020). Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186723"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.redox.2016.01.006","article-title":"Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes","volume":"8","author":"Kanzaki","year":"2016","journal-title":"Redox Biol."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Kang, I.S., and Kim, C. (2016). NADPH oxidase gp91phox contributes to RANKL-induced osteoclast differentiation by upregulating NFATc1. Sci. Rep., 6.","DOI":"10.1038\/srep38014"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"ziae066","DOI":"10.1093\/jbmrpl\/ziae066","article-title":"Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma","volume":"8","author":"Zerlotin","year":"2024","journal-title":"JBMR Plus"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5618\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:50:26Z","timestamp":1760032226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":110,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ijms26125618"],"URL":"https:\/\/doi.org\/10.3390\/ijms26125618","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]}}}